nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
Adjunctive Eslicarbazepine Acetate in Pediatric Patients with Focal Epilepsy: A Systematic Review and Meta-Analysis
|
Lattanzi, Simona |
|
2018 |
32 |
3 |
p. 189-196 |
artikel |
2 |
A Double-Blind, Placebo-Controlled, Phase II Study to Determine the Efficacy, Safety, Tolerability and Pharmacokinetics of a Controlled Release (CR) Formulation of Mazindol in Adults with DSM-5 Attention-Deficit/Hyperactivity Disorder (ADHD)
|
Wigal, Tim L. |
|
2018 |
32 |
3 |
p. 289-301 |
artikel |
3 |
Author Correction to: l-Acetyl-carnitine in Patients with Carpal Tunnel Syndrome: Effects on Nerve Protection, Hand Function and Pain
|
Cruccu, Giorgio |
|
2018 |
32 |
3 |
p. 303 |
artikel |
4 |
Convergent Mechanisms Underlying Rapid Antidepressant Action
|
Zanos, Panos |
|
2018 |
32 |
3 |
p. 197-227 |
artikel |
5 |
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
|
Faissner, Simon |
|
|
32 |
3 |
p. 269-287 |
artikel |
6 |
Efficacy and Safety of the Newer Multiple Sclerosis Drugs Approved Since 2010
|
Faissner, Simon |
|
2018 |
32 |
3 |
p. 269-287 |
artikel |
7 |
Gadolinium-Based Contrast Agent-Related Toxicities
|
Pasquini, Luca |
|
2018 |
32 |
3 |
p. 229-240 |
artikel |
8 |
Long-Acting Injectable Second-Generation Antipsychotics: An Update and Comparison Between Agents
|
Jann, Michael W. |
|
2018 |
32 |
3 |
p. 241-257 |
artikel |
9 |
Newer Antiepileptic Drugs for Status Epilepticus in Adults: What’s the Evidence?
|
Beuchat, Isabelle |
|
2018 |
32 |
3 |
p. 259-267 |
artikel |